Factors influencing the development of a personal tailored microbiota in the neonate, with particular emphasis on antibiotic therapy

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue SUPPL.2, 2013, Pages 35-43

  Faa, Gavino ^a   Gerosa, Claudia ^a   Fanni, Daniela ^a   Nemolato, Sonia ^a   Van Eyken, Peter ^b   Fanos, Vassilios ^a  

^a University Hospital San Giovanni di Dio   (Italy)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Antibiotics; Microbiome; Microbiota; Newborn

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; IMIPENEM; LEVOFLOXACIN; VANCOMYCIN;

ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; ARTIFICIAL MILK; ATOPOBIUM; AUTOIMMUNE DISEASE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTEROIDES; BIFIDOBACTERIACEAE; CESAREAN SECTION; CHILDHOOD DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CORYNEBACTERIUM; DIARRHEA; DISEASE PREDISPOSITION; HUMAN; IMMUNE SYSTEM; INTESTINE MUCOSA; LACTOBACILLUS; LACTOBACILLUS GASSERI; LACTOBACILLUS INERS; LACTOBACILLUS JENSENII; LACTOBACILLUS VAGINALIS; MICROBIAL COMMUNITY; MICROBIOME; MICROFLORA; MOLECULAR INTERACTION; NEWBORN; PREVOTELLA; PRIORITY JOURNAL; PROPIONIBACTERIUM; PROTEIN EXPRESSION; REVIEW; SINGLE DRUG DOSE; STAPHYLOCOCCUS; STREPTOCOCCUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VAGINAL DELIVERY;

ANTI-BACTERIAL AGENTS; BIOLOGICAL EVOLUTION; CHILD DEVELOPMENT; GASTROINTESTINAL TRACT; HUMANS; INDIVIDUALITY; INFANT, NEWBORN; INTESTINAL MUCOSA; MICROBIOTA; PARTURITION;

EID: 84884664631     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.829700     Document Type: Review

References (53)

1. Lee YK, Manzmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 2010;330: 1768-73.
2. Quin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
3. Johnson CL, Varsalovic J. The human microbiome and its potential importance to pediatrics. Pediatrics 2012;129:950-60.
4. Blaser MJ. Who are we? Indigenous microbes and the ecology of human diseases. EMBO Reports 2006;7:956-60.
5. Ottman N, Smidt H, de Vos WM, Belzer C. The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol 2012;2:104.
6. Mshvildadze M, Neu J. The infant intestinal microbiome: friend or foe? Early Hum Dev 2010;86:S67-71.
7. Manichanh C, Reeder J, Gibert P, et al. Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res 2010;20:1411-9.
8. Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology 2011;140:1713-9.
9. Muegge BD, Kuczynski J, Knights D, et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011;332:970-4.
10. Martin F-PJ, Collino S, Rezzi S, Kochhar S. Metabolomic application to decipher gut microbial metabolic influence in health and disease. Front Physiol 2012;3:113.
11. Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006;118:511-21.
12. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature 2007;449:804-10.
13. Di Giulio DB. Source of infection leading to preterm death. J Perinat Med 2010;38:495-502.
14. Kramer MR, Hogue C. Place matters: variation in the black/white very preterm birth rate across U.S. metropolitan areas. 2002-2004. Public Health Rep 2008;123:576-85.
15. Ackermann G, Thomalla S, Ackermann F, et al. Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea. J Med Microbiol 2005;54: 149-53.
16. Donders G, Bellen G, Rezeberga D. Aerobic vaginitis in pregnancy. BJOG 2011;118:1163-70.
17. Biasucci G, Benenati B, Morelli L, et al. Cesarean delivery may affect the early biodiversity of the intestinal bacteria. J Nutr 2008; 138:1796S-800S.
18. Biasucci G, Rubini M, Riboni S, et al. mode of delivery affects the bacterial community in the newborn gut. Early Hum Dev 2010;86: 13-15.
19. Gronlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999;28:19-25.
20. Arboleya S, Binetti A, Salazar N, et al. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol Ecol 2012;79:763-72.
21. Poroyko V, Morowitz M, Bell T, et al. Diet creates metabolic niches in the "immature gut" that shape microbial communities. Nutr Hosp 2011;26:1283-95.
22. Zivkovic AM, German JB, Lebrilla CB, Mills DA. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. PNAS 2011;108:4653-8.
23. Bezirtzoglou E, Stavropoulou E. Immunology and probiotic impact of the newborn and young children intestinal microflora. Anaerobe 2011;17:369-74.
24. Palmer C, Bik EM, Di Giulio DB, et al. Development of the human infant intestinal microbiota. PlosBiol 2007;5:e177.
25. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. PNAS 2011;108:4680-7.
26. Ishii M, Toda T, Ikarashi N, et al. Effects of intestinal flora on the expression of cytochrome P4503A in the liver. Yakugaku Zasshi 2012;132:301-10.
27. Kinross JM, Darzi AW, Nicholson JK. Gut microbiome-host interactions in health and disease. Genome Med 2011;3:14.
28. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition microflora by toll-like receptors is required for intestinal homeo-stasis. Cell 2004;118:229-41.
29. Rook GA, Brunet LR. Microbes immunoregulation and the gut. Gut 2005;54:317-20.
30. Madara J. Building an intestine-architectural contributions of comensal bacteria. N Engl J Med 2004;351:1685-6.
31. Collado MC, Cernada M, Bauerl C, et al. Microbial ecology and host-microbiota interactions during early life stages. Gut Microbes 2012;3:352-65.
32. Rautava S, Luoto R, Salminen S, Isolauri E. Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenetrol Hepatol 2012;9:565-76.
33. Rohde CL, Bartolini V, Jones N. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea. Nutr ClinPract 2009;24:33-40.
34. De La Cpchetière MF, Durand T, Lalande V, et al. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol 2008;56: 395-402.
35. Gorkiewicz G. Nosocomial and antibiotic-associated diarrhea caused by organisms other than Clostridium difficile. Int J Antimicrob Agents 2009;33:37-41.
36. Son HJ, Lim YC, Ha KS, et al. Propofol and aminophylline antagonize each other during the mobilization of intracellular calcium in human umbilical vein endothelial cells. J Korean Med Sci 2010;25:222-7.
37. Johnston BC, Goldenberg JZ, Vandvik PO, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2011;11:CD004827.
38. Schumann A, Nutten S, Donnicola D, et al. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics 2005; 23:309-18.
39. Mshvildadze M, Neu J, Schuster J, et al. Intestinal microbial ecology in premature infants assessed with non-culture-based techniques. J Pediatr 2010;156:20-5.
40. Westerbeek EA, van den Berg A, Lafeber HN, et al. The intestinal bacterial colonization in preterm infants: a review of the literature. Clin Nutr 2006;25:361-8.
41. Collignon A, Sandré C, Barc MC. Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antimicrobic treatment. Gastroenterol Clin Biol 2010;34:71-8.
42. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-asociate diarrhea. J Clin Gastroenterol 2010;44:354-60.
43. Surawicz CM. The microbiota and infectious diarrhea. Gastroenterol Clin Biol 2010;34:29-36.
44. Toda T, Ohi K, Kudo T, et al. Antibiotics suppress Cyp3a in the mouse liver by reducing lithocholic acid-producing intestinal flora. Yakugaku Zasshi 2009;129:601-8.
45. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. PNAS USA 2011;1:4554-61.
46. Buffie CG, Jarchum I, Equinda M, et al. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun 2012;80:62-73.
47. Willing BP, Russell SL, Finlay BB. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 2011;9: 233-43.
48. Relman DA. The human microbiome: ecosystem resilience and health. Netr Rev 2012;1:2-9.
49. Costello EK, Stagaman K, Dethlefsen L, et al. The application of ecological theory toward an understanding of the human micro-biome. Science 2012;336:1255-62.
50. Heinken A, Sahoo S, Fleming RMT, Thiele I. System-level characterization of a host-microbe metabolic symbiosis in the mammalian gut. Gut Microbes 2013;4:1-13.
51. Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 2009;136:2015-31.
52. Grover S, Rashmi HM, Srivastava AK, Batish VK. Probiotics for human health. New innovations and emerging trends. Gut Pathogens 2012;4:15.
53. Claus SP, Ellero SL, Berger B, et al. Colonization-induced host-gut microbial metabolic interaction. mBio 2011;2:e00271-10.